Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
INTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.
Saved in:
Main Authors: | Lalit Saini, Jack T Seki, Deepali Kumar, Eshetu G Atenafu, David EC Cole, Betty YL Wong, Andrea Božović, Joseph M Brandwein |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2014/214813 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
by: Coleman Rotstein, et al.
Published: (2008-01-01) -
Corneal Debridement Combined with Intrastromal Voriconazole for Recalcitrant Fungal Keratitis
by: Yajie Sun, et al.
Published: (2018-01-01) -
Successful Treatment of Candida parapsilosis Fungemia in Two Preterms with Voriconazole
by: Emel Altuncu, et al.
Published: (2015-01-01) -
Two Case Presentations Infected by Trichosporon asahii and Treated with Voriconazole Successfully
by: Hikmet Gulsah Tanyildiz, et al.
Published: (2015-01-01) -
Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
by: Santiago Grau, et al.
Published: (2015-10-01)